MLL1 Regulates T-Cell Phenotype via Notch Signaling During Abdominal Aortic Aneurysm Development.

IF 8.8 1区 医学 Q1 HEMATOLOGY
Xiaobing He, Nicholas Juriga, Brennan Callow, Sama Salih, Amrita Joshi, Rachael Bogle, Lam C Tsoi, Andrea T Obi, Johann E Gudjonsson, Katherine A Gallagher, Frank M Davis
{"title":"MLL1 Regulates T-Cell Phenotype via Notch Signaling During Abdominal Aortic Aneurysm Development.","authors":"Xiaobing He, Nicholas Juriga, Brennan Callow, Sama Salih, Amrita Joshi, Rachael Bogle, Lam C Tsoi, Andrea T Obi, Johann E Gudjonsson, Katherine A Gallagher, Frank M Davis","doi":"10.1161/ATVBAHA.126.324552","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Abdominal aortic aneurysms (AAA) are characterized by progressive pathological vascular remodeling and a dysregulated immune microenvironment marked by an imbalance between anti-inflammatory regulatory T cells and proinflammatory T helper 17 (Th17) cells within the aortic wall. The molecular mechanisms governing CD4<sup>+</sup> (cluster of differentiation) T-cell differentiation during AAA development remain incompletely defined. MLL1 (mixed lineage leukemia 1), a histone methyltransferase, has recently been shown to modulate T-cell lineage commitment through epigenetic regulation of transcriptional programs in multiple inflammatory diseases. We, therefore, sought to determine whether MLL1 promotes Th17 polarization during AAA development and to identify signaling pathways through which MLL1 regulates CD4<sup>+</sup> T-cell infiltration and phenotype.</p><p><strong>Methods: </strong>Single-cell RNA-sequencing was performed on human AAA and nonaneurysmal aortic tissues. Two murine AAA models were utilized: AngII (angiotensin II) infusion with adeno-associated virus-mediated PCSK9 (proprotein convertase subtilisin/kexin type 9) gain-of-function expression and topical porcine pancreatic elastase application in C57BL/6J mice. Mice with CD4<sup>+</sup> T-cell-specific deletion of Notch signaling (<i>DNMAML</i><sup><i>fl/fl</i></sup><i>CD4</i><sup><i>cre+</i></sup>), Notch1 (<i>Notch1</i><sup><i>fl/fl</i></sup><i>CD4</i><sup><i>cre+</i></sup>), or MLL1 (<i>Mll1</i><sup><i>fl/fl</i></sup><i>CD4</i><sup><i>cre+</i></sup>) were subjected to AngII infusion, and aneurysm diameter was quantified. CD4<sup>+</sup> T cells were isolated by magnetic-activated cell sorting for gene expression analysis and flow cytometric phenotyping. Chromatin immunoprecipitation assessed H3K4 trimethylation enrichment at target gene promoters.</p><p><strong>Results: </strong>Single-cell sequencing of human AAA tissue demonstrated marked upregulation of MLL1 and Notch1 signaling in CD4<sup>+</sup> T cells compared with controls. Both human AAA and murine AngII-induced AAA CD4<sup>+</sup> T cells exhibited a predominant Th17 phenotype with increased MLL1 expression. Chromatin immunoprecipitation analysis revealed enhanced MLL1-mediated H3K4 trimethylation enrichment at the Notch1 promoter. Mice deficient in CD4<sup>+</sup> Th-cell Notch signaling (<i>DNMAML</i><sup><i>fl/fl</i></sup><i>CD4</i><sup><i>cre+</i></sup> or <i>Notch1</i><sup><i>fl/fl</i></sup><i>CD4</i><sup><i>cre+</i></sup>) or MLL1 (<i>Mll1</i><sup><i>fl/fl</i></sup><i>CD4</i><sup><i>cre+</i></sup>) displayed a significant reduction in aneurysm formation, decreased Th17 activity, and increased regulatory T cell expression.</p><p><strong>Conclusions: </strong>MLL1 epigenetically regulates Notch1 signaling to drive pathogenic Th17 polarization during AAA development. Targeting the MLL1 axis may represent a novel therapeutic strategy to limit aneurysmal progression.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":"e324552"},"PeriodicalIF":8.8000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13496003/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.126.324552","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/20 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Abdominal aortic aneurysms (AAA) are characterized by progressive pathological vascular remodeling and a dysregulated immune microenvironment marked by an imbalance between anti-inflammatory regulatory T cells and proinflammatory T helper 17 (Th17) cells within the aortic wall. The molecular mechanisms governing CD4+ (cluster of differentiation) T-cell differentiation during AAA development remain incompletely defined. MLL1 (mixed lineage leukemia 1), a histone methyltransferase, has recently been shown to modulate T-cell lineage commitment through epigenetic regulation of transcriptional programs in multiple inflammatory diseases. We, therefore, sought to determine whether MLL1 promotes Th17 polarization during AAA development and to identify signaling pathways through which MLL1 regulates CD4+ T-cell infiltration and phenotype.

Methods: Single-cell RNA-sequencing was performed on human AAA and nonaneurysmal aortic tissues. Two murine AAA models were utilized: AngII (angiotensin II) infusion with adeno-associated virus-mediated PCSK9 (proprotein convertase subtilisin/kexin type 9) gain-of-function expression and topical porcine pancreatic elastase application in C57BL/6J mice. Mice with CD4+ T-cell-specific deletion of Notch signaling (DNMAMLfl/flCD4cre+), Notch1 (Notch1fl/flCD4cre+), or MLL1 (Mll1fl/flCD4cre+) were subjected to AngII infusion, and aneurysm diameter was quantified. CD4+ T cells were isolated by magnetic-activated cell sorting for gene expression analysis and flow cytometric phenotyping. Chromatin immunoprecipitation assessed H3K4 trimethylation enrichment at target gene promoters.

Results: Single-cell sequencing of human AAA tissue demonstrated marked upregulation of MLL1 and Notch1 signaling in CD4+ T cells compared with controls. Both human AAA and murine AngII-induced AAA CD4+ T cells exhibited a predominant Th17 phenotype with increased MLL1 expression. Chromatin immunoprecipitation analysis revealed enhanced MLL1-mediated H3K4 trimethylation enrichment at the Notch1 promoter. Mice deficient in CD4+ Th-cell Notch signaling (DNMAMLfl/flCD4cre+ or Notch1fl/flCD4cre+) or MLL1 (Mll1fl/flCD4cre+) displayed a significant reduction in aneurysm formation, decreased Th17 activity, and increased regulatory T cell expression.

Conclusions: MLL1 epigenetically regulates Notch1 signaling to drive pathogenic Th17 polarization during AAA development. Targeting the MLL1 axis may represent a novel therapeutic strategy to limit aneurysmal progression.

MLL1通过Notch信号调控腹主动脉瘤发育过程中的t细胞表型。
背景:腹主动脉瘤(AAA)的特征是进行性病理性血管重构和免疫微环境失调,其特征是主动脉壁内抗炎调节性T细胞和促炎T辅助17 (Th17)细胞之间的失衡。在AAA发育过程中,控制CD4+ t细胞分化的分子机制尚未完全确定。MLL1(混合谱系白血病1)是一种组蛋白甲基转移酶,最近被证明在多种炎症疾病中通过表观遗传调控转录程序来调节t细胞谱系的承诺。因此,我们试图确定MLL1是否在AAA发育过程中促进Th17极化,并确定MLL1调节CD4+ t细胞浸润和表型的信号通路。方法:对人AAA和非动脉瘤性主动脉组织进行单细胞rna测序。采用两种小鼠AAA模型:血管紧张素II (AngII)输注腺相关病毒介导的PCSK9(蛋白转化酶枯草杆菌素/ keexin 9型)功能获得表达和猪胰腺弹性酶外用C57BL/6J小鼠。对CD4+ t细胞特异性缺失Notch信号(DNMAMLfl/flCD4cre+)、Notch1 (Notch1fl/flCD4cre+)或MLL1 (Mll1fl/flCD4cre+)的小鼠进行AngII输注,并对动脉瘤直径进行量化。采用MACS分离CD4+ T细胞进行基因表达分析和流式细胞术表型分析。染色质免疫沉淀评估H3K4在靶基因启动子上的三甲基化富集。结果:人AAA组织的单细胞测序显示,与对照组相比,CD4+ T细胞中的MLL1和Notch1信号明显上调。人AAA和小鼠血管诱导的AAA CD4+ T细胞均表现出主要的Th17表型,MLL1表达增加。ChIP分析显示,Notch1启动子上mll1介导的H3K4三甲基化富集增强。CD4+ th细胞Notch信号(DNMAMLfl/flCD4cre+或Notch1fl/flCD4cre+)或MLL1 (Mll1fl/flCD4cre+)缺失的小鼠动脉瘤形成显著减少,Th17活性降低,调节性T细胞表达增加。结论:在AAA发育过程中,MLL1通过表观遗传调控Notch1信号驱动致病性Th17极化。靶向MLL1轴可能是一种限制动脉瘤进展的新治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书